Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907335 · ClinicalTrials.gov registry record · Phase 2
A Study of Acne Treatment in Children Ages 9 to 11
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00907335 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 110 participants.
The verdict
NCT00907335, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
A study to determine if using Retin-A Micro 0.04% as facial acne treatment in patients ages 9 to 11 is safe and efficacious.
Interventions
- DRUG Vehicle control
- DRUG Retin-A Micro 0.04% facial acne treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907335
The ClinicalTrials.gov registry entry for NCT00907335 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle control is the first listed.
NCT00907335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00907335 about?
NCT00907335 is a clinical study titled "A Study of Acne Treatment in Children Ages 9 to 11". A study to determine if using Retin-A Micro 0.04% as facial acne treatment in patients ages 9 to 11 is safe and efficacious.
What is the current status of trial NCT00907335?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2009-02. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00907335?
The interventions under investigation include: Vehicle control (DRUG), Retin-A Micro 0.04% facial acne treatment (DRUG).
Who is sponsoring clinical trial NCT00907335?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.